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The efficacy and technical aspects of endobronchial ultrasound (EBUS) are reviewed because
this technology promises to revolutionise bronchoscopy. EBUS extends the endoscopist’s view
beyond the mucosal surface of the large airways to peri-bronchial structures and peripheral
lung lesions. Guided biopsies and real-time transbronchial needle aspirations (TBNA) have been
shown to increase the diagnostic yield over conventional bronchoscopic techniques. The tech-
nology is available in two forms: radial EBUS probes and linear EBUSeTBNA bronchoscopes.
Radial EBUS utilizes higher frequencies and the transducer is inserted via a standard flexible
bronchoscope. The higher ultrasound frequencies improve image resolution to <1 mm. Radial
EBUS is used to assess airway walls, guide TBNA (diagnostic yield: 72e86%) and diagnose
peripheral lung lesions (diagnostic yield: 61e80%). Linear EBUSeTBNA transducers are built
into dedicated bronchoscopes to produce sector view images and permit real-time TBNA.
The pooled sensitivity of real-time EBUSeTBNA in lung cancer is 90% but the false negative rate
is 20%. Therefore, EBUSeTBNA is a viable alternative to cervical mediastinoscopy in the diag-
nosis and staging of mediastinal lymphadenopathy. However, negative results need either
further confirmatory testing or adequate clinical follow-up. Complications are rare with either
EBUS modality and are usually related to the underlying biopsy procedure rather than the use
of ultrasound. Procedure duration is short enough to be incorporated into an outpatient setting
and can performed under moderate sedation. Clear training standards are emerging to facili-
tate credentialing as EBUS is rapidly evolving to become a part of standard diagnostic bron-
choscopy.
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1. Endobronchial ultrasound (EBUS) is available in 2 types
of transducers: radial EBUS and linear EBUSeTBNA.
2. Radial EBUS probes utilize 20 MHz transducers to
provide high resolution images and are inserted via
a standard therapeutic bronchoscope into the airways.
3. Radial EBUS probes facilitate airway wall assessment,
guided TBNA and guided biopsies of peripheral lung
lesions.
4. Linear EBUS transducers are built into a dedicated
bronchoscope to provide real-time sector views.
5. Linear EBUSeTBNA facilitates diagnosis and staging of
mediastinal and hilar lymph node stations.Figure 1 Radial EBUS transducer probes. A: ‘Peripheral’
probe that utilizes guide sheaths without balloons to locate
peripheral lung lesions. B: ‘Central’ probe that employs
balloon sheaths to assess airway walls and identify lymph
nodes.Introduction
Flexible bronchoscopy has been limited to by the extent of
the endoscopist’s view. Endobronchial ultrasound (EBUS)
has revolutionised bronchoscopy because it extends vision
beyond the airway walls to both peri-bronchial structures
and distal peripheral lung lesions. A detailed assessment of
the airway wall layers, as well as, guided biopsies of lymph
nodes and tumors is now possible. This comprehensive
review aims to assess the efficacy of EBUS as a diagnostic
modality and describe the relevant technical aspects. EBUS
technology is currently available in two forms: radial and
linear transducer probes.
Ultrasound images are generated when high frequency
sound energy is emitted by a transducer, reflected off
a tissue interface, then received by the same transducer
and finally processed. The challenge of ultrasonography of
the lungs is related to the acoustic properties of air, which
reflects ultrasound waves and permits no transmission. This
results in images with multiple artefacts and obscures
structures within the thorax that are not air-filled. By
miniaturizing transducer probes such that they can be
inserted via flexible bronchoscopy, these limitations are
overcome because mediastinal and peri-bronchial struc-
tures can be visualized without intervening alveoli
obscuring the view.Radial EBUS
Radial EBUS has a 20-MHz (12e30 MHz available) rotating
transducer that can be inserted together with or without
a guide sheath through the working channel (2.0e2.8 mm)
of a standard flexible bronchoscope. Radial EBUS trans-
ducer probes come in different sizes with external diame-
ters of 1.4e2.6 mm. ‘Central’ probes are utilised with
balloon sheaths in the proximal airways for either bronchial
wall assessment or to guide TBNA of lymph nodes (Fig. 1).
Coupling between the transducer and the bronchial mucosa
is achieved by inflating the balloon that surrounds the
transducer with sterile water. Saline can result in salt
crystallization and is avoided. EBUS ‘peripheral’ probes
without balloon sheaths are used to identify parenchymal
lung lesions for biopsy (Fig. 1). In the distal airways
1408 D. Anantham et al.coupling is unnecessary because the small airway calibre
ensures good contact between the transducer and the
mucosal walls. In radial EBUS, a 360-degree image that is
perpendicular to the long axis of the airway is produced.
The resolution of the image is <1 mm and a depth of 4e
5 cm is scanned.
Radial EBUS is typically performed after standard bron-
choscopic examination of the tracheobronchial tree. The
radial probe should not be active i.e. not rotating when it is
inserted into the working channel of the bronchoscope.
This reduces damage to the delicate piezoelectric trans-
ducer. Most patients can tolerate inflation of the coupling
balloon in even the trachea for short periods of time under
moderate sedation without any ventilation problems or
discomfort. Once an image in obtained, the ultrasound view
and endoscopic view need to be matched using familiar
landmarks such as major vessels (anechoic), spine and
esophagus. In the trachea, EBUS orientation is easier
because it is similar to axial computed tomography (CT)
scans. However, this orientation becomes more challenging
as the scanning axis changes to an oblique angle in the main
stem bronchi and more distal airways. Therefore,
a detailed understanding of thoracic anatomy is mandatory
for the successful use of EBUS.
Airway assessment
Airway walls can be examined using radial EBUS and up to
7 layers of the wall can be distinguished.1 The mucosa,
endochondium, perichondrium and adventitia are hyper-
echoic (white) while the intervening submucosa, cartilage
and connective tissue layer are hypoechoic (grey). EBUS
has been shown to be superior to even CT scanning in
distinguishing airway wall invasion from extrinsic
compression by a tumor with a sensitivity of 89% and
specificity of 100%.1 By identifying evidence of cartilage
invasion by tumors, patients can be excluded from
endoscopic modalities such as photodynamic therapy or
brachytherapy in favour of surgical modalities.2,3 EBUS
can also guide interventional bronchoscopy. Stent under
sizing is avoided by identifying submucosal tumor
involvement and airway malacia. Fatal hemoptysis can be
prevented by visualizing adjacent blood vessels before
debridement or thermal ablation.3,4
EBUS guided biopsies of lymph nodes
The relationship of extraluminal lymph nodes and tumors
relative to the airways is easily visualized using EBUS. Once
a target lesion is identified, the probe is removed and TBNA
can be performed. Although, radial EBUS facilitates guided
biopsies, it is limited by the absence of real-time sampling.
The reported diagnostic yields with radial EBUS directed
TBNA is 72e86%5e8 and this guided procedure has been
shown to improve diagnostic rates over ‘blind’ conventional
TBNA in mediastinal lymph node stations 2, 3 and 4.7
EBUS guided biopsies of peripheral lung lesions
Radial EBUS can be used to guide biopsies of peripheral lung
lesions and increases the diagnostic yield of transbronchiallung biopsies of smaller (<20e30 mm) lesions.9 Diagnostic
sensitivities of 61e80% that are independent of lesion size
have been reported using peripheral radial EBUS probes
(Table 1). However, there is great variability in the exper-
tise and experience of the operators in the reported data.
Combining data is also impossible because of variations in
the use of guide sheaths, fluoroscopy, and biopsy methods
such as forceps biopsy, brushing or needle aspiration.
Nevertheless, EBUS appears to remove variables such as
presence of CT bronchus sign, underlying disease and lobar
location from affecting diagnostic yield.10 The use of EBUS
guided transbronchial lung biopsy without fluoroscopic
guidance has also been safe and effective.11,12
EBUS guided biopsy of peripheral lung lesions is rela-
tively uncomplicated. The transducer probe is inserted
through a guide sheath into the bronchi where the lesion is
suspected based on pre-procedure radiological imaging.
Normal air-filled alveoli produce a whitish snowstorm image
with ‘comet-tail’ artefacts. Peripheral lung lesions are
usually hypoechoic (Fig. 2).13 Ultrasonographic features
indicative of malignancy are the presence of a continuous
margin around the lesion, heterogeneous echogenicity and
the absence of linear air bronchograms.14 A combination of
such features increases the positive predictive value for
malignancy further.14
When sonographic images of peripheral lesions are seen
all around the probe on the screen, the probe can be
considered to be situated within the target. The transducer
is then removed and regular biopsy forceps are used to take
biopsies through the guide sheath. Biopsies of lesions where
the probe is within the lesion have been shown to have
higher diagnostic rates than when the probe is adjacent to
the lesions and the optimum number of biopsies is reported
to be about 5 specimens.10,15 Endobronchial washing and
brushing specimens can be obtained in a similar manner.
The use of needle aspirations together with forceps biopsy
may increase the diagnostic yield further especially if the
transducer probe cannot be redirected such that it lies
within rather than adjacent to the peripheral lung lesion.15
Successful biopsy of small and fluoroscopically invisible
nodules is also possible with diagnostic rates of 70%.16 It
may be more difficult and time consuming to locate these
small peripheral lung lesions but if they can be found by
EBUS then the diagnostic yield appears to be unaffected by
the size of the lesion (Table 1). Double-hinged curettes and
electromagnetic navigation bronchoscopy can be used to
navigate the EBUS probes to such peripheral lung lesions to
further improve diagnostic yields.12,17,18Linear EBUSeTBNA
The linear EBUS probe has been built into a dedicated
flexible bronchoscope to enable real-time TBNA biopsies
(Fig. 3). This EBUS bronchoscope has an external diameter
of 6.9 mm which is larger than a standard flexible bron-
choscope. Therefore, oral rather than nasal intubation is
necessary. The endoscopic viewing optics is at a 30-degree
oblique angle and operator compensation is required when
manoeuvring the bronchoscope. Particular attention is
needed in intubating the trachea and often only the
anterior apex of the vocal cords is visible as the scope
Table 1 Yield by lesion size in studies of radial EBUS directed bronchoscopic diagnosis of peripheral lung lesions. Diagnostic
yield includes both true positives and true negatives.
Series Technique Number
of lesions
Mean lesion
size in mm
Diagnostic
yield in %
Paone G et al.9 EBUS-transbronchial forceps biopsy 25
47 <20 71
40 <30 75
>30 83
Yamada N et al.10 EBUS-transbronchial forceps biopsy with guide sheath 158 21  6 67
40 <15 40
118 >15 76
Yoshikawa M et al.11 EBUS-transbronchial forceps biopsy
and brushing with guide sheath (Fluoroscopy not used)
123 31  16 62
37 <20 30
86 >20 76
Chao Ty et al.15 EBUS eTBNA, forceps biopsy and washing
EBUS forceps biopsy and washing
88 35  10 78
94 35  8 61
Herth F et al.16 EBUS e transbronchial forceps biopsy 54 22  0.7 70
Kikuchi E et al.17 EBUS with guide sheath and
fluoroscopy  curette e forceps biopsy/brush
24 <30 58
15 <20 53
9 20-30 67
Asahina H et al.18 EBUS with guide sheath, virtual bronchoscopy navigation
and fluoroscopy  curette - forceps biopsy/brush
30 <30 63
18 <20 44
12 20-30 92
Kurimoto N et al.43 EBUS with guide sheath and
fluoroscopy  curette e forceps biopsy/brush
81 <20 73
43 20-30 77
26 >30 92
Herth F et al.47 EBUS e transbronchial forceps biopsy 50 33  9.2 80
21 <30 80
29 >30 79
Yang MC et al.48 EBUS e transbronchial forceps biopsy 11 <20 55
103 >20 66
Shirakawa T et al.49 EBUS and fluoroscopy  curette eforceps biopsy/brush
(21 cases with guide sheath)
50 - 84
Asano F et al.50 EBUS-transbronchial forceps biopsy and brush with guide sheath 32 21 84
Koh MS et al.51 EBUS-transbronchial forceps biopsy with guide sheath 29 35 62
Fielding DI et al.52 EBUS-transbronchial forceps biopsy with guide sheath 140 29 66
Dooms CA et al.53 EBUS-transbronchial forceps biopsy 50 37  20 84
Endobronchial ultrasound 1409enters the subglottic space. Usually endobronchial exami-
nation is limited because of the restricted and oblique
endoscopic view. Therefore, standard bronchoscopy may
also be needed to complete a full airway examination. The
7.5 MHz EBUS transducer is convex and has a 50-degree
sector view parallel to the long axis of the bronchoscope
extending 20e50 mm in depth. This bronchoscope has
a 2.0-mm working channel that can house a dedicated 22 G
biopsy needle. This needle has multiple small dimples on
its shaft to enhance echogenicity and improve visualization
on the screen. The needle also has an internal diameter
which is equivalent to a 21-G needle and the depth of
penetration can be varied from 5 to 40 mm with a safety
lock.
After endobronchial intubation, the EBUSeTBNA scope is
positioned at the approximate location of the target lymphnode or paratracheal tumor. The scope is flexed to gain
contact with the airway wall and then withdrawn gently
while being rotated from side to side. Although there is
a balloon that can be filled with sterile water or saline to
facilitate coupling, this is not always needed if good
contact can be maintained between the airway mucosal
surface and the probe. Simultaneous imaging of the endo-
scopic and ultrasound images, as well as, a detailed
knowledge of mediastinal anatomy facilitates the process
of locating the targeted peri-bronchial lesions. Lymph
nodes appear more echoic (grey) than blood vessels and
colour Doppler can be used to assist in making the
distinction. Preliminary data is also emerging in the use of
power Doppler (Aloka 5, Aloka, Japan) to measure vascular
resistive index of lymph nodes.19 Malignant nodes appear to
have a higher resistive index because of neovascularisation.
Figure 4 Real-time EBUSeTBNA with 22 G needle within
lymph node station 4L.Figure 2 Radial EBUS image of the transducer probe within
a peripheral lung lesion that was proven to be adenocarcinoma
on histology.
1410 D. Anantham et al.Using such sonographic features, it may be possible in
future to focus sampling on certain targeted lymph nodes
that at high risk of malignancy.
Once the target lymph nodes or tumor is identified, real-
time TBNA is performed. The needle sheath is pushed
forward such that it is visualized on the endoscopic image
before the ‘jabbing’ technique is used to perform TBNA
under real-time guidance (Fig. 4). Visualization of the
needle sheath prevents inadvertent puncture of the bron-
choscope by the aspiration needle. Once the TBNA needle is
within the target, the stylet of the needle is agitated to
dislodge any airway debris before being removed for biop-
sies to be aspirated. Most mediastinal and hilar lymph nodes
are accessible to the EBUSeTBNA bronchoscope except the
aorto-pulmonary (station 5), sub-aortic (station 6), para-
esophageal (station 8) and pulmonary ligament (station 9)
nodes. For mediastinal staging of non-small cell lung
cancer, 3 cytology aspirations per lymph node station is
recommended. If an adequate core specimen in obtained,
then 2 passes will suffice.20Figure 3 Linear EBUSeTBNA bronchoscope with needle
protruding through guide sheath.EBUSeTBNA mediastinal staging
Despite recommendations for pathological staging before
surgical resection of non-small cell lung cancer, pre-oper-
ative staging with mediastinoscopy has been reported in
only 27% of patients.21 Among these patients who under-
went mediastinoscopy only 47% had any evidence of lymph
node tissue submitted to pathology.21 These alarming data
suggest that a guided and more easily available procedure
to stage the mediastinum is needed. As an outpatient
procedure that does not require the need for general
anesthesia, EBUS may be able to fill this gap in patient care.
Real-time EBUSeTBNA has been shown to have a higher
diagnostic yield in mediastinal staging than blind TBNA and
may be comparable in sensitivity to cervical mediastino-
scopy.22,23 The pooled diagnostic sensitivity is 90% and
specificity is 100%, but the false negative rate remains high
at about 20%.24 Combined analysis of the available data is
confounded by the differing prevalence of malignancy, the
size of the lymph nodes targeted, the use of pre-procedure
imaging such as positron-emission tomography, the number
of needle passes, the expertise of the endoscopists and the
availability of on-site cytology (Table 2).
Even without the presence of rapid on-site cytology,
diagnostic yields of 88e100% have been reported for real-
time EBUSeTBNA (Table 2). Despite the encouraging results
of the diagnostic yield, the high false negative rates
mandate that all negative results need to be either fol-
lowed up clinically or subject to further testing using
alternative modalities such as mediastinoscopy to confirm
that the results are true negatives. If on-site cytology is
used, the majority of true negative aspirates have
moderate to abundant lymphocyte yields suggesting that
lymphocyte number is a marker for sample adequacy.25
The histological staging of a normal mediastinum based
on CT-scan i.e lymphadenopathy 10 mm is also
feasible.26,27 In addition, the dedicated 22 G EBUSeTBNA
needle can obtain samples that are sufficient for genetic
and molecular analysis (e.g. epidermal growth factor
receptor mutations).28 Re-staging the mediastinum after
neoadjuvant chemotherapy has had less success with
a reported diagnostic sensitivity of only 76% and a negative
predictive value that remains at 20%.29
Table 2 Diagnostic accuracy and definitive histological yield in studies of real-time EBUS-TBNA sampling of mediastinal and
hilar lymph nodes. Diagnostic yield is calculated based on true positives and true negatives. Denominators are provided for
diagnostic accuracy and definitive histology to highlight that some studies used a per lesion based calculation while others used
a per patient based calculation.
Series n Prevalence of
malignancy in the
mediastinum (%)
Number of
lymph nodes
sampled
Lymph node
size mm
(range)
Diagnostic
Yield (%)
Definitive
histological
yield (%)
Lee HS et al.20 102 32/102 (31) 163 (5-20) 100/102 (98) 30/102 (29)
Ernst A et al.23 66 59/66 (89) 120 15  2.6 109/120 (91) 71/120 (59)
Herth F et al.26 100 21/100 (21) 119 8.1  0.7 (4e10) 117/119 (98) 22/119 (19)
Herth F et al.27 100 9/100 (9) 156 7.9  0.7 (5-10) 99/100 (99) 8/100 (8)
Kennedy MP et al.31 25 11/25 (44) 49 (7-40) 24/25 (96) 10/25 (40)
Herth F et al.46 502 493/502 (98) 572 16  3.6 (8e32) 470/502 (94) 470/502 (94)
Krasnik M et al.54 11 10/11 (91) 15 (7e80) 15/15 (100) 13/15 (87)
Yasufuku K et al.55y 70 47/70 (67) 70 ( 30) 68/70 (97) 50/70 (71)
Rintoul RC et al.56 19 11/19 (58) 26 (6e20) 15/17 (88) 11/17 (65)
Yasufuku K et al.57
y35 overlap patients
108 68/108 (63) 163 13 (8e30) 104/108 (96) 64/108 (59)
Yasufuku K et al.58 102 26/102 (25) 200 8.7 (5e22) 100/102 (98) 24/102 (24)
Szlubowski A et al.59 226 145/226 (64) 320 13.8  9 210/226 (93) 129/226 (57)
Hwangbo B et al.60 117 30/117 (26) 223 (5-20) 114/117 (97) 27/117 (23)
Rintoul RC et al.61 109 86/109 (77) 127 - 102/109 (95) 77/109 (71)
Vincent BD et al.62 113 100 167 - 112/113 (99) 66/167 (40)
Nakajima T et al.63 43 25/43 (58) 60 13.1 (3-35) 41/43 (95) 23/43 (54)
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ultrasound-guided fine needle aspiration (EUSeFNA) can
enable complete staging of the mediastinum with access to
lymph node stations not accessible to either technique on
its own. Diagnostic sensitivities of 93e94% have been
reported for the combined EBUS and EUS procedure.22,30
EBUS offers greater access to the paratracheal and hilar
lymph node stations while EUS can target inferior medias-
tinal lymph nodes and adrenal metastases.
Other applications
EBUSeTBNA has also been shown to have utility in diag-
noses besides lung cancer. In patients with clinically sus-
pected lymphoma, the reported diagnostic sensitivity is
91%.31 In the demonstration of non-caseating granuloma-
tous inflammation, EBUSeTBNA has a diagnostic yield for
sarcoidosis of 85e94%.32e34 If more tissue specimens are
needed for histological analysis, it is even possible to insert
a 1.15-mm mini-forceps through the EBUS scope and past
the airway wall via a needle puncture to obtain real-time
guided forceps biopsies of mediastinal lymph nodes.35
EBUSeTBNA has also been used to successfully obtain
biopsy specimens in centrally located paratracheal and
peri-bronchial tumors with a diagnostic sensitivity of
82e94%.36,37 Furthermore, real-time guided EBUSeTBNA
has been used therapeutically to drain mediastinal, as well
as bronchogenic cysts and consequently relieve central
airway obstruction.38,39
Setting up an EBUS service
Key considerations before embarking on an EBUS program
include viability of service, cost of equipment,reimbursement for procedures and training of both endo-
scopists, as well as support staff. The endoscopy patient
load must be large enough to justify the time and resources
invested in this new service. Minimum numbers of 10e25
procedures per year for each physician to maintain
competency in each EBUS modality also need to be met.41,42
Costs of new equipment encompass dedicated broncho-
scopes (EBUSeTBNA), transducer probes (radial) and ultra-
sound processors. Furthermore, the delicate radial EBUS
probe has a life span of about only 20 procedures if carefully
maintained. Consumables that have to be accounted for
include specific EBUSeTBNA needles, guide sheaths,
balloons and biopsy forceps. Reimbursement for time,
investment and expertise for EBUS continues to pose a chal-
lenge in many diverse health systems around the world.
Beyond the immediatebenefits of enhanceddiagnostic yield,
a true cost analysis needs to consider the cost of avoiding
repeated procedures because of negative results from
‘blind’ procedures, as well as, the cost of avoiding alterna-
tive procedures such asmediastinoscopy or CT guidedbiopsy.
Training endoscopists to perform EBUS will cover image
interpretation, ‘knobology’ which is the use of the ultra-
sound processor controls, orientation of endoscopic and
ultrasound views, as well as, biopsy techniques. Knowledge
of thoracic anatomy and competence in basic flexible
bronchoscopy/TBNA are pre-requisites. The American
College of Chest Physicians recommends at least 50 proc-
tored procedures to gain competence in EBUS and 5e10
procedures per year to maintain the skill.40 The European
Respiratory Society and American Thoracic Society joint
statement suggest 40 supervised procedures for trainees
and 25 procedures per year to maintain competency.41
These guidelines are for radial EBUS and no similar recom-
mendations are available for real-time linear EBUSeTBNA.
However, data suggest that after as few as 10 procedures
1412 D. Anantham et al.the diagnostic accuracy rises from 50 to 96%.42 Complica-
tions have not been attributed directly to either EBUS
modality. Radial EBUS guided lung biopsies of peripheral
lesions has a reported rate of pneumothorax of 0e5%9,12 and
risk of moderate bleeding of 1%43 which is in keeping with
the complication rates expected with regular transbronchial
lung biopsies.44,45 Therefore, these can be considered
complications of forceps biopsy rather than EBUS imaging.
EBUS can also add to endoscopy time initially and this
has implications for what can be achieved under moderate
sedation. However, in expert hands radial EBUS adds
<3 min to TBNA and about 60 s to the transbronchial biopsy
of peripheral lesions.7,43 Linear EBUSeTBNA has been
reported to take a mean of 12.5 min (range 8e21).46 Other
issues that need to be addressed when starting an EBUS
service will be training of endoscopy staff to re-process
EBUS probes/scopes and assist in procedures.
Conclusion
Radial EBUS and linear EBUS have contrasting features and
applications. Radial EBUS produces high resolution, 360-
degree images and is inserted via a standard flexible
bronchoscope. It facilitates the detailed evaluation of the
central airway walls, as well as peripheral lung lesions.
However, any biopsy procedures guided by radial EBUS are
not real-time. Linear EBUS generates relatively lower
resolution sector scans compared to the radial transducer.
Although imaging is confined to lesions around the central
airways, the advantage is that TBNA is performed real-time
because the transducer is built into a dedicated broncho-
scope. Therefore, only by combining both EBUS techniques
can endoscopists offer a more comprehensive service in
diagnostic bronchoscopy.
EBUS has the potential to become part of standard
bronchoscopy because of negligible complications,
improved diagnostic yield and short learning curve. It
enhances pathological staging of the mediastinum in non-
small cell lung cancer and increases the yields in the diag-
nosis of both peri-bronchial and peripheral lung lesions.
Resolution of the mucosa is still limited by ultrasound at
even the highest frequencies in the sound spectrum.
Therefore, there is a limited role for EBUS in mucosal lesions
compared to light based modalities such as auto-
fluorescence bronchoscopy and narrow band imaging.
However, the depth of penetration of ultrasonographic
waves enables the endoscopist to view beyond the surface
of the airway walls and target deep structures. This ability
to ‘see throughwalls’ without the need for ionizing radiation
remains the premise on which EBUS has been developed.
Conflict of interest statement
All authors declare that we have no conflicts of interests to
report.
References
1. Herth F, Ernst A, Schulz M, Becker H. Endobronchial ultrasound
reliably differentiates between airway infiltration and
compression by tumor. Chest 2003;123(2):458e62.2. Miyazu Y, Miyazawa T, Kurimoto N, Iwamoto Y, Kanoh K,
Kohno N. Endobronchial ultrasonography in the assessment of
centrally located early-stage lung cancer before photodynamic
therapy. Am J Respir Crit Care Med 2002;165(6):832e7.
3. Herth F, Becker HD, LoCicero 3rd J, Ernst A. Endobronchial
ultrasound in therapeutic bronchoscopy. Eur Respir J 2002;
20(1):118e21.
4. Miyazawa T, Miyazu Y, Iwamoto Y, et al. Stenting at the flow-
limiting segment in tracheobronchial stenosis due to lung
cancer. Am J Respir Crit Care Med 2004;169(10):1096e102.
5. Shannon JJ, Bude RO, Orens JB, et al. Endobronchial ultra-
sound-guided needle aspiration of mediastinal adenopathy. Am
J Respir Crit Care Med 1996;153(4 Pt 1):1424e30.
6. Plat G, Pierard P, Haller A, et al. Endobronchial ultrasound and
positron emission tomography positive mediastinal lymph
nodes. Eur Respir J 2006;27(2):276e81.
7. Herth F, Becker HD, Ernst A. Conventional vs endobronchial
ultrasound-guided transbronchial needle aspiration: a random-
ized trial. Chest 2004;125(1):322e5.
8. Herth FJ, Becker HD, Ernst A. Ultrasound-guided trans-
bronchial needle aspiration: an experience in 242 patients.
Chest 2003;123(2):604e7.
9. Paone G, Nicastri E, Lucantoni G, et al. Endobronchial ultra-
sound-driven biopsy in the diagnosis of peripheral lung lesions.
Chest 2005;128(5):3551e7.
10. Yamada N, Yamazaki K, Kurimoto N, et al. Factors related to
diagnostic yield of transbronchial biopsy using endobronchial
ultrasonography with a guide sheath in small peripheral
pulmonary lesions. Chest 2007;132(2):603e8.
11. Yoshikawa M, Sukoh N, Yamazaki K, et al. Diagnostic value of
endobronchial ultrasonography with a guide sheath for
peripheral pulmonary lesions without X-ray fluoroscopy. Chest
2007;131(6):1788e93.
12. Eberhardt R, Anantham D, Ernst A, Feller-Kopman D, Herth F.
Multimodality bronchoscopic diagnosis of peripheral lung
lesions: a randomized controlled trial. Am J Respir Crit Care
Med 2007;176(1):36e41.
13. Lie CH, Chao TY, Chung YH, Wang JL, Wang YH, Lin MC. New
image characteristics in endobronchial ultrasonography for
differentiating peripheral pulmonary lesions. Ultrasound Med
Biol; 2008 Dec 23 [Epub ahead of print].
14. Kuo CH, Lin SM, Chen HC, Chou CL, Yu CT, Kuo HP. Diagnosis of
peripheral lung cancer with three echoic features via endo-
bronchial ultrasound. Chest 2007;132(3):922e9.
15. Chao TY, Chien MT, Lie CH, Chung YH, Wang JL, Lin MC.
Endobronchial ultrasonography-guided transbronchial needle
aspiration increases the diagnostic yield of peripheral pulmo-
nary lesions: a randomized trial. Chest; 2008 Sep 23 [Epub
ahead of print].
16. Herth FJ, Eberhardt R, Becker HD, Ernst A. Endobronchial
ultrasound-guided transbronchial lung biopsy in fluoroscopi-
cally invisible solitary pulmonary nodules: a prospective trial.
Chest 2006;129(1):147e50.
17. Kikuchi E, Yamazaki K, Sukoh N, et al. Endobronchial ultraso-
nography with guide-sheath for peripheral pulmonary lesions.
Eur Respir J 2004;24(4):533e7.
18. Asahina H, Yamazaki K, Onodera Y, et al. Transbronchial biopsy
using endobronchial ultrasonography with a guide sheath and
virtual bronchoscopic navigation. Chest 2005;128(3):1761e5.
19. Herth F, Eberhardt R, Mulay T, Anantham D, Ernst A. Resistive
index through EBUS in enlarged mediastinal lymph nodes
correlates with malignant involvement. Chest 2007;132:
465Se6S.
20. Lee HS, Lee GK, Lee HS, et al. Real-time endobronchial
ultrasound-guided transbronchial needle aspiration in medi-
astinal staging of non-small cell lung cancer: how many aspi-
rations per target lymph node station? Chest 2008;134(2):
368e74.
Endobronchial ultrasound 141321. Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical
care of lung cancer patients. Ann Thorac Surg 2005;80(6):
2051e6.
22. Wallace MB, Pascual JM, Raimondo M, et al. Minimally invasive
endoscopic staging of suspected lung cancer. JAMA 2008;
299(5):540e6.
23. Ernst A, Anantham D, Eberhardt R, Krasnik M, Herth FJ. Diag-
nosis of mediastinal adenopathy-real-time endobronchial
ultrasound guided needle aspiration versus mediastinoscopy.
J Thorac Oncol 2008;3(6):577e82.
24. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J,
Silvestri GAAmerican College of Chest Physicians. Invasive
mediastinal staging of lung cancer: ACCP evidence-based
clinical practice guidelines (2nd edition). Chest 2007;132(3
Suppl.):202Se20S.
25. Alsharif M, Andrade RS, Groth SS, Stelow EB, Pambuccian SE.
Endobronchial ultrasound-guided transbronchial fine-needle
aspiration: the University of Minnesota experience, with
emphasis on usefulness, adequacy assessment, and diagnostic
difficulties. Am J Clin Pathol 2008;130(3):434e43.
26. Herth FJ, Ernst A, Eberhardt R, Vilmann P, Dienemann H,
Krasnik M. Endobronchial ultrasound-guided transbronchial
needle aspiration of lymph nodes in the radiologically normal
mediastinum. Eur Respir J 2006;28(5):910e4.
27. Herth FJ, Eberhardt R, Krasnik M, Ernst A. Endobronchial
ultrasound-guided transbronchial needle aspiration of lymph
nodes in the radiologically and positron emission tomography-
normal mediastinum in patients with lung cancer. Chest 2008
Apr;133(4):887e91.
28. Nakajima T, Yasufuku K, Suzuki M, et al. Assessment of
epidermal growth factor receptor mutation by endobronchial
ultrasound-guided transbronchial needle aspiration. Chest
2007;132(2):597e602.
29. Herth FJ, Annema JT, Eberhardt R, et al. Endobronchial
ultrasound with transbronchial needle aspiration for restaging
the mediastinum in lung cancer. J Clin Oncol 2008;26(20):
3346e50.
30. Herth FJ, Lunn W, Eberhardt R, Becker HD, Ernst A. Trans-
bronchial versus transesophageal ultrasound-guided aspiration
of enlarged mediastinal lymph nodes. Am J Respir Crit Care
Med 2005;171(10):1164e7.
31. Kennedy MP, Jimenez CA, Bruzzi JF, et al. Endobronchial
ultrasound-guided transbronchial needle aspiration in the
diagnosis of lymphoma. Thorax 2008;63(4):360e5.
32. Oki M, Saka H, Kitagawa C, et al. Real-time endobronchial
ultrasound-guided transbronchial needle aspiration is useful
for diagnosing sarcoidosis. Respirology 2007;12(6):863e8.
33. Wong M, Yasufuku K, Nakajima T, et al. Endobronchial ultra-
sound: new insight for the diagnosis of sarcoidosis. Eur Respir
J 2007;29(6):1182e6.
34. Garwood S, Judson MA, Silvestri G, Hoda R, Fraig M, Doelken P.
Endobronchial ultrasound for the diagnosis of pulmonary
sarcoidosis. Chest 2007;132(4):1298e304.
35. Herth FJ, Morgan RK, Eberhardt R, Ernst A. Endobronchial
ultrasound-guided miniforceps biopsy in the biopsy of sub-
carinal masses in patients with low likelihood of non-small cell
lung cancer. Ann Thorac Surg 2008;85(6):1874e8.
36. Tournoy KG, Rintoul RC, van Meerbeeck JP, et al. EBUSeTBNA
for the diagnosis of central parenchymal lung lesions not visible
at routine bronchoscopy. Lung Cancer 2009;63(1):45e9.
37. Nakajima T, Yasufuku K, Fujiwara T, et al. Endobronchial
ultrasound-guided transbronchial needle aspiration for the
diagnosis of intrapulmonary lesions. J Thorac Oncol 2008;3(9):
985e8.
38. Nakajima T, Yasufuku K, Shibuya K, Fujisawa T. Endobronchial
ultrasound-guided transbronchial needle aspiration for the
treatment of central airway stenosis caused by a mediastinal
cyst. Eur J Cardiothorac Surg 2007;32(3):538e40.39. Dhand S, Krimsky W. Bronchogenic cyst treated by endobron-
chial ultrasound drainage. Thorax 2008;63(4):386.
40. Ernst A, Silvestri GA, Johnstone DAmerican College of Chest
Physicians. Interventional pulmonary procedures: guidelines
from the American College of Chest Physicians. Chest 2003;
123(5):1693e717.
41. Bolliger CT, Mathur PN, Beamis JF, et alEuropean Respiratory
Society/American Thoracic Society. ERS/ATS statement on
interventional pulmonology. European Respiratory Soci-
ety/American Thoracic Society. Eur Respir J 2002;19(2):
356e73.
42. Groth SS, Whitson BA, D’Cunha J, Maddaus MA, Alsharif M,
Andrade RS. Endobronchial ultrasound-guided fine-needle
aspiration of mediastinal lymph nodes: a single institution’s
early learning curve. Ann Thorac Surg 2008;86(4):1104e10.
43. Kurimoto N, Miyazawa T, Okimasa S, et al. Endobronchial
ultrasonography using a guide sheath increases the ability to
diagnose peripheral pulmonary lesions endoscopically. Chest
2004;126(3):959e65.
44. Izbicki G, Shitrit D, Yarmolovsky A, et al. Is routine chest
radiography after transbronchial biopsy necessary?: a prospec-
tive study of 350 cases. Chest 2006;129(6):1561e4.
45. Herth FJ, Becker HD, Ernst A. Aspirin does not increase
bleeding complications after transbronchial biopsy. Chest
2002;122(4):1461e4.
46. Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A. Real-time
endobronchial ultrasound guided transbronchial needle aspi-
ration for sampling mediastinal lymph nodes. Thorax 2006;
61(9):795e8.
47. Herth FJ, Ernst A, Becker HD. Endobronchial ultrasound-guided
transbronchial lung biopsy in solitary pulmonary nodules and
peripheral lesions. Eur Respir J 2002;20(4):972e4.
48. Yang MC, Liu WT, Wang CH, et al. Diagnostic value of endo-
bronchial ultrasound-guided transbronchial lung biopsy in
peripheral lung cancers. J Formos Med Assoc 2004;103:124e9.
49. Shirakawa T, Imamura F, Hamamoto J, et al. Usefulness of
endobronchial ultrasonography for transbronchial lung biopsies
of peripheral lung lesions. Respiration 2004;71(3):260e8.
50. Asano F, Matsuno Y, Tsuzuku A, et al. Diagnosis of peripheral
pulmonary lesions using a bronchoscope insertion guidance
system combined with endobronchial ultrasonography with
a guide sheath. Lung Cancer 2008;60(3):366e73.
51. Koh MS, Tee A, Wong P, Antippa P, Irving LB. Advances in lung
cancer diagnosis and staging: endobronchial ultrasound. Intern
Med J 2008;38(2):85e9.
52. Fielding DI, Robinson PJ, Kurimoto N. Biopsy site selection for
endobronchial ultrasound guide-sheath transbronchial biopsy
of peripheral lung lesions. Intern Med J 2008;38(2):77e84.
53. Dooms CA, Verbeken EK, Becker HD, Demedts MG,
Vansteenkiste JF. Endobronchial ultrasonography in broncho-
scopic occult pulmonary lesions. J Thorac Oncol 2007;2(2):
121e4.
54. Krasnik M, Vilmann P, Larsen SS, Jacobsen GK. Preliminary
experience with a new method of endoscopic transbronchial
real time ultrasound guided biopsy for diagnosis of mediastinal
and hilar lesions. Thorax 2003;58(12):1083e6.
55. Yasufuku K, Chiyo M, Sekine Y, et al. Real-time endobronchial
ultrasound-guided transbronchial needle aspiration of medi-
astinal and hilar lymph nodes. Chest 2004;126(1):122e8.
56. Rintoul RC, Skwarski KM, Murchison JT, Wallace WA,
Walker WS, Penman ID. Endobronchial and endoscopic ultra-
sound-guided real-time fine-needle aspiration for mediastinal
staging. Eur Respir J 2005;25(3):416e21.
57. Yasufuku K, Chiyo M, Koh E, et al. Endobronchial ultrasound
guided transbronchial needle aspiration for staging of lung
cancer. Lung Cancer 2005;50(3):347e54.
58. Yasufuku K, Nakajima T, Motoori K, et al. Comparison of
endobronchial ultrasound, positron emission tomography, and
1414 D. Anantham et al.CT for lymph node staging of lung cancer. Chest 2006;130(3):
710e8.
59. Szlubowski A, Ku _zd _zał J, Kołodziej M, et al. Endobronchial
ultrasound-guided needle aspiration in the non-small cell lung
cancer staging. Eur J Cardiothorac Surg; 2008 Oct 24 [Epub
ahead of print].
60. Hwangbo B, Kim SK, Lee HS, et al. Application of endobronchial
ultrasound-guided transbronchial needle aspiration following
integrated positron emission tomography/CT in mediastinal
staging of potentially operable non-small cell lung cancer.
Chest; 2008 Dec 31 [Epub ahead of print].61. Rintoul RC, Tournoy KG, El Daly H, et al. EBUSeTBNA for the
clarification of PET positive intra-thoracic lymph nodes-an inter-
nationalmulti-centreexperience.JThoracOncol2009;4(1):44e8.
62. Vincent BD, El-Bayoumi E, Hoffman B, et al. Real-time endo-
bronchial ultrasound-guided transbronchial lymph node aspi-
ration. Ann Thorac Surg 2008;85(1):224e30.
63. Nakajima T, Yasufuku K, Iyoda A, et al. The evaluation of
lymph node metastasis by endobronchial ultrasound-guided
transbronchial needle aspiration: crucial for selection of
surgical candidates with metastatic lung tumors. J Thorac
Cardiovasc Surg 2007;134(6):1485e90.
